Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Доказательная база эффективности препарата Траумель® С - Справочник поликлинического врача №2 (2017)
Доказательная база эффективности препарата Траумель® С
Доказательная база эффективности препарата Траумель® С. Справочник поликлинического врача. 2017; 2: 53–59.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В статье приведены данные интегративного обзора эффективности и безопасности препарата Траумель® С при использовании в комплексной терапии воспалительных заболеваний разных органов и тканей, включая, в частности, заболевания опорно-двигательного аппарата (тендовагинит, бурсит, стилоидит, периартрит и т.д.) и посттравматических состояний (послеоперационный отек мягких тканей, растяжение мышц и связок). Траумель® С – многокомпонентный препарат, обладающий многоцелевым действием на воспалительно-иммунную сеть.
Цель работы: обзор доказательных данных в отношении эффективности применения препарата Траумель® C по основному зарегистрированному показанию.
Методы. Анализ данных по определению уровня доказательности проводился с использованием иерархической системы оценки и неиерархическими методами, применялась категория «Терапевтическая польза вмешательства» шкалы уровня доказательности данных Оксфордского центра доказательной медицины.
Результаты. Терапевтическая польза применения препарата Траумель® С подтверждается исследованиями с различным уровнем доказательности данных: 6 клинических исследований, оцененных как исследования 2-го уровня доказательности; 7 обсервационных исследований – 3-го уровня; 7 фундаментальных исследований – 5-го уровня.
Обсуждение. Существует широкий спектр доказательных данных 2-го уровня, свидетельствующих об эффективности препарата Траумель® С при лечении острых растяжений, травм и остеоартроза коленного сустава.
Ключевые слова: заболевания опорно-двигательного аппарата, боль, биорегуляционные препараты, клинические исследования, Траумель С.
Objective: to review evidence supporting the efficacy of Traumeel® S on the basis of the main recorded indication.
Methods. Analysis of data on the level of evidence was conducted using a hierarchical assessment system and non-hierarchical methods, the category "Therapeutic use of intervention" of the evidence-level scale of the Oxford Center for Evidence-Based Medicine was used.
Results. The therapeutic benefit of using Traumeel® S is confirmed by studies with different levels of evidence: 6 clinical studies evaluated as Level 2 evidence; 7 observational studies - level 3; 7 fundamental research – level 5.
Discussion. There is a wide range of evidence level 2 evidence of the effectiveness of Traumeel® S in the treatment of acute distension, injury and osteoarthritis of the knee joint.
Key words: diseases of the musculoskeletal system, pain, bioregulation drugs, clinical studies, Traumeel S.
Цель работы: обзор доказательных данных в отношении эффективности применения препарата Траумель® C по основному зарегистрированному показанию.
Методы. Анализ данных по определению уровня доказательности проводился с использованием иерархической системы оценки и неиерархическими методами, применялась категория «Терапевтическая польза вмешательства» шкалы уровня доказательности данных Оксфордского центра доказательной медицины.
Результаты. Терапевтическая польза применения препарата Траумель® С подтверждается исследованиями с различным уровнем доказательности данных: 6 клинических исследований, оцененных как исследования 2-го уровня доказательности; 7 обсервационных исследований – 3-го уровня; 7 фундаментальных исследований – 5-го уровня.
Обсуждение. Существует широкий спектр доказательных данных 2-го уровня, свидетельствующих об эффективности препарата Траумель® С при лечении острых растяжений, травм и остеоартроза коленного сустава.
Ключевые слова: заболевания опорно-двигательного аппарата, боль, биорегуляционные препараты, клинические исследования, Траумель С.
________________________________________________
Objective: to review evidence supporting the efficacy of Traumeel® S on the basis of the main recorded indication.
Methods. Analysis of data on the level of evidence was conducted using a hierarchical assessment system and non-hierarchical methods, the category "Therapeutic use of intervention" of the evidence-level scale of the Oxford Center for Evidence-Based Medicine was used.
Results. The therapeutic benefit of using Traumeel® S is confirmed by studies with different levels of evidence: 6 clinical studies evaluated as Level 2 evidence; 7 observational studies - level 3; 7 fundamental research – level 5.
Discussion. There is a wide range of evidence level 2 evidence of the effectiveness of Traumeel® S in the treatment of acute distension, injury and osteoarthritis of the knee joint.
Key words: diseases of the musculoskeletal system, pain, bioregulation drugs, clinical studies, Traumeel S.
Полный текст
Список литературы
1. Неврология. Национальное руководство. Под ред. Е.И.Гусева, А.Н.Коновалова, В.И.Скворцовой, А.Б.Гехт. М.: ГЭОТАР-Медиа, 2009. / Nevrologiia. Natsional'noe rukovodstvo. Pod red. E.I.Guseva, A.N.Konovalova, V.I.Skvortsovoi, A.B.Gekht. M.: GEOTAR-Media, 2009. [in Russian]
2. Andersson G. Epidemiological features of chronic low back pain. Lancet 1999; 354: 581–6.
3. Van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth 2013; 1: 13–8.
4. Oren O, Ablin J. Precision medicine: the emerging approach to the chronic pain patient. Int J Clin Rheumtol 2013; 4: 491–9.
5. Боль: современные подходы в диагностике и лечении. Неврология и Ревматология (Прил. к журн. Consilium Medicum). 2016; 1; 55–7. / Pain: current approaches in diagnosis and treatment. Neurology and Rheumatology (Suppl. Consilium Medicum). 2016; 1; 55–7. [in Russian]
6. Хайне Х. Иммунологическая воспалительная реакция, вызванная антигомотоксической терапией воспалительных заболеваний суставов. Биологическая мед. 1999; 1: 5–8. / Khaine Kh. Immunologicheskaia vospalitel'naia reaktsiia, vyzvannaia antigomotoksicheskoi terapiei vospalitel'nykh zabolevanii sustavov. Biologicheskaia med. 1999; 1: 5–8. [in Russian]
7. Пилипович А.А. Хроническая боль при заболеваниях опорно-двигательного аппарата: применение антигомотоксических препаратов. Consilium Medicum. 2016; 18 (9): 128–32. / Pilipovich A.A. Chronic pain in diseases of the musculoskeletal system: the use of antihomotoxic medications. Consilium Medicum. 2016; 18 (9): 128–32. [in Russian]
8. Van Haselen R. An Integrative Review of the Evidence on the Antihomotoxic Medication Traumeel. 1–29.
9. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. CEBM Web site. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf. Accessed February 22, 2017.
10. Schneider C. Traumeel: an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med 2011; 4: 225–34.
11. Müller-Löbnitz C, Göthel D. Review of the clinical efficacy of the multicomponent combination medication Traumeel and its components. Altern Ther Health Med 2011; 17 (Suppl. 2): s18–s31.
12. Speed C, Wolfarth B. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Curr Med Res Opin 2014; 30 (5): 953–9.
13. Conforti A, Bertani S, Metelmann H et al. Experimental studies on the anti-inflammatory activity of a homeopathic preparation. Biomed Ther 1997; 15 (1): 28–31.
14. Conforti A, Bertani S, Lussignoli S, Bellavite P. Wirkungen Antihomotoxischer Präparate auf akute und chronische Entzündungen. Biol Medizin 1998; 27 (2): 63–6.
15. Enbergs H. The effect of selected potentiated suis organ preparations and Traumeel on phagocyte and lymphocyte activity. Biomed Ther 1998; 16 (2): 178–85.
16. Lussignoli S, Bertani S, Metelmann H et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med 1999; 7 (4): 225–30.
17. Heine H, Andrä F. On the anti-inflammatory mechanism of action of an antihomotoxic compound remedy [in German]. Ärztezeitschriftfür Naturheilverfahren 2002; 43 (2): 96–104.
18. Porozov S, Cahalon L, Weiser M et al. Inhibition of IL-1b and TNF-a secretion from resting and activated human immunocytes by the homeopathic medication Traumeel® S. Clin Dev Immunol 2004; 11 (2): 143–9.
19. Seilheimer B, Wierzchacz C, Gebhardt R. Influence of Traumeel on cultured chondrocytes and recombinant human matrix metalloproteinases: implications for chronic joint diseases. Eur J Integr Med 2009; 1 (4): 252–3.
20. St Laurent G, Tackett M, McCaffrey T, Kapranov P. Deep sequencing transcriptome analysis of Traumeel therapeutic action in wound healing (THU0016). Ann Rheum Dis 2013; 72 (Suppl. 3).
21. Zell J, Connert WD, Mau J, Feuerstake G. Behandlung von Sprunggelenksdistorsionen: Doppelblindstudie zum Wirksamkeitsnachweis eines homöopathischen Salbenpräparats. Fortschr Med 1988; 106 (5): 96–100.
22. Zell J, Connert WD, Mau J, Feuerstake G. Treatment of acute sprains of the ankle: a controlled double-blind trial to test the effectiveness of a homeopathic ointment. Biol Ther 1989; 7 (1): 1–6.
23. Thiel W, Borho B. Posttraumatische Kniegelenksergüsse und intraartikuläre Traumeel-N-Injektion. Orthopädische Prax 1991; 27 (11): 721–5.
24. Thiel W, Borho B. The treatment of recent traumatic blood effusions of the knee joint. Biol Ther 1994; 12 (4): 242–8.
25. Böhmer D, Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled double-blind study. Biol Ther 1992; 10 (4): 290–300.
26. Arora S, Harris T, Scherer C. Clinical safety of a homeopathic preparation. Biomed Ther 2000; 18 (2): 222–5.
27. González de Vega C, Speed C, Wolfarth B, González J. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: A multicentre, randomised, blinded, controlled and non-inferiority trial. Int J Clin Pract 2013; 67 (10): 979–89.
28. González de Vega C, Gonzáles J. A randomized, controlled, multicenter study on the effectiveness of Traumeel (ointment and gel) in terms of pain reduction and function improvement compared with diclofenac gel in acute ankle sprain. Ann Rheum Dis 2012; 71 (Suppl. 3): SAT0423.
29. Lozada C, del Rio E, Reitberg D et al. A multi-center double-blind, randomized, controlled trial (db-RCT) to evaluate the effectiveness and safety of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections versus IA placebo in patients with moderate-to-severe pain associated with OA of the knee. Arthritis Rheum 2014; 66 (Suppl.): S1266.
30. Lozada C, del Rio E, Reitberg DP et al. Risk-benefit of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections in patients with moderate-to-severe pain associated with OA of the knee (OAK) (THU0441). Ann Rheum Dis 2015; 74 (Suppl. 2): 4268.
31. Zenner S, Metelmann H. Application possibilities of Traumeel S injection solution: Results of a multicentric drug monitoring trial conducted on 3,241 patients. Biol Ther 1992; 10 (4): 301–10.
32. Zenner S, Metelmann H. Therapy experiences with a homeopathic ointment: Results of drug surveillance conducted on 3,422 patients. Biol Ther 1994; 12 (3): 204–11.
33. Weiser M, Zenner S. Orale Therapie traumatischer, entzündlicher und degenerativer Affektionen mit einem Homöopathikum. Biol Medizin 1996; 25 (5): 211–16.
34. Zenner S, Weiser M. Oral treatment of traumatic, inflammatory, and degenerative conditions with a homeopathic remedy. Biomed Ther 1997; 15 (1): 22–6.
35. Ludwig J, Weiser M. Treating pediatric trauma with a homeopathic ointment. J Biomed Ther 2001; 2: 8–11.
36. Birnesser H, Oberbaum M, Klein P, Weiser M. The homeopathic preparation Traumeel S compared with NSAIDs for symptomatic treatment of epicondylitis. J Musculoskelet Res 2004; 8 (2, 3): 119–28.
37. Schneider C, Klein P, Stolt P, Oberbaum M. A homeopathic ointment preparation compared with 1% diclofenac gel for acute symptomatic treatment of tendinopathy. Explore (NY). 2005; 1 (6): 446–52.
38. Schneider C, Schneider B, Hanisch J, van Haselen R. The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med 2008; 16 (1): 22–7.
2. Andersson G. Epidemiological features of chronic low back pain. Lancet 1999; 354: 581–6.
3. Van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth 2013; 1: 13–8.
4. Oren O, Ablin J. Precision medicine: the emerging approach to the chronic pain patient. Int J Clin Rheumtol 2013; 4: 491–9.
5. Pain: current approaches in diagnosis and treatment. Neurology and Rheumatology (Suppl. Consilium Medicum). 2016; 1; 55–7. [in Russian]
6. Khaine Kh. Immunologicheskaia vospalitel'naia reaktsiia, vyzvannaia antigomotoksicheskoi terapiei vospalitel'nykh zabolevanii sustavov. Biologicheskaia med. 1999; 1: 5–8. [in Russian]
7. Pilipovich A.A. Chronic pain in diseases of the musculoskeletal system: the use of antihomotoxic medications. Consilium Medicum. 2016; 18 (9): 128–32. [in Russian]
8. Van Haselen R. An Integrative Review of the Evidence on the Antihomotoxic Medication Traumeel. 1–29.
9. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. CEBM Web site. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf. Accessed February 22, 2017.
10. Schneider C. Traumeel: an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med 2011; 4: 225–34.
11. Müller-Löbnitz C, Göthel D. Review of the clinical efficacy of the multicomponent combination medication Traumeel and its components. Altern Ther Health Med 2011; 17 (Suppl. 2): s18–s31.
12. Speed C, Wolfarth B. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Curr Med Res Opin 2014; 30 (5): 953–9.
13. Conforti A, Bertani S, Metelmann H et al. Experimental studies on the anti-inflammatory activity of a homeopathic preparation. Biomed Ther 1997; 15 (1): 28–31.
14. Conforti A, Bertani S, Lussignoli S, Bellavite P. Wirkungen Antihomotoxischer Präparate auf akute und chronische Entzündungen. Biol Medizin 1998; 27 (2): 63–6.
15. Enbergs H. The effect of selected potentiated suis organ preparations and Traumeel on phagocyte and lymphocyte activity. Biomed Ther 1998; 16 (2): 178–85.
16. Lussignoli S, Bertani S, Metelmann H et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med 1999; 7 (4): 225–30.
17. Heine H, Andrä F. On the anti-inflammatory mechanism of action of an antihomotoxic compound remedy [in German]. Ärztezeitschriftfür Naturheilverfahren 2002; 43 (2): 96–104.
18. Porozov S, Cahalon L, Weiser M et al. Inhibition of IL-1b and TNF-a secretion from resting and activated human immunocytes by the homeopathic medication Traumeel® S. Clin Dev Immunol 2004; 11 (2): 143–9.
19. Seilheimer B, Wierzchacz C, Gebhardt R. Influence of Traumeel on cultured chondrocytes and recombinant human matrix metalloproteinases: implications for chronic joint diseases. Eur J Integr Med 2009; 1 (4): 252–3.
20. St Laurent G, Tackett M, McCaffrey T, Kapranov P. Deep sequencing transcriptome analysis of Traumeel therapeutic action in wound healing (THU0016). Ann Rheum Dis 2013; 72 (Suppl. 3).
21. Zell J, Connert WD, Mau J, Feuerstake G. Behandlung von Sprunggelenksdistorsionen: Doppelblindstudie zum Wirksamkeitsnachweis eines homöopathischen Salbenpräparats. Fortschr Med 1988; 106 (5): 96–100.
22. Zell J, Connert WD, Mau J, Feuerstake G. Treatment of acute sprains of the ankle: a controlled double-blind trial to test the effectiveness of a homeopathic ointment. Biol Ther 1989; 7 (1): 1–6.
23. Thiel W, Borho B. Posttraumatische Kniegelenksergüsse und intraartikuläre Traumeel-N-Injektion. Orthopädische Prax 1991; 27 (11): 721–5.
24. Thiel W, Borho B. The treatment of recent traumatic blood effusions of the knee joint. Biol Ther 1994; 12 (4): 242–8.
25. Böhmer D, Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled double-blind study. Biol Ther 1992; 10 (4): 290–300.
26. Arora S, Harris T, Scherer C. Clinical safety of a homeopathic preparation. Biomed Ther 2000; 18 (2): 222–5.
27. González de Vega C, Speed C, Wolfarth B, González J. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: A multicentre, randomised, blinded, controlled and non-inferiority trial. Int J Clin Pract 2013; 67 (10): 979–89.
28. González de Vega C, Gonzáles J. A randomized, controlled, multicenter study on the effectiveness of Traumeel (ointment and gel) in terms of pain reduction and function improvement compared with diclofenac gel in acute ankle sprain. Ann Rheum Dis 2012; 71 (Suppl. 3): SAT0423.
29. Lozada C, del Rio E, Reitberg D et al. A multi-center double-blind, randomized, controlled trial (db-RCT) to evaluate the effectiveness and safety of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections versus IA placebo in patients with moderate-to-severe pain associated with OA of the knee. Arthritis Rheum 2014; 66 (Suppl.): S1266.
30. Lozada C, del Rio E, Reitberg DP et al. Risk-benefit of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections in patients with moderate-to-severe pain associated with OA of the knee (OAK) (THU0441). Ann Rheum Dis 2015; 74 (Suppl. 2): 4268.
31. Zenner S, Metelmann H. Application possibilities of Traumeel S injection solution: Results of a multicentric drug monitoring trial conducted on 3,241 patients. Biol Ther 1992; 10 (4): 301–10.
32. Zenner S, Metelmann H. Therapy experiences with a homeopathic ointment: Results of drug surveillance conducted on 3,422 patients. Biol Ther 1994; 12 (3): 204–11.
33. Weiser M, Zenner S. Orale Therapie traumatischer, entzündlicher und degenerativer Affektionen mit einem Homöopathikum. Biol Medizin 1996; 25 (5): 211–16.
34. Zenner S, Weiser M. Oral treatment of traumatic, inflammatory, and degenerative conditions with a homeopathic remedy. Biomed Ther 1997; 15 (1): 22–6.
35. Ludwig J, Weiser M. Treating pediatric trauma with a homeopathic ointment. J Biomed Ther 2001; 2: 8–11.
36. Birnesser H, Oberbaum M, Klein P, Weiser M. The homeopathic preparation Traumeel S compared with NSAIDs for symptomatic treatment of epicondylitis. J Musculoskelet Res 2004; 8 (2, 3): 119–28.
37. Schneider C, Klein P, Stolt P, Oberbaum M. A homeopathic ointment preparation compared with 1% diclofenac gel for acute symptomatic treatment of tendinopathy. Explore (NY). 2005; 1 (6): 446–52.
38. Schneider C, Schneider B, Hanisch J, van Haselen R. The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med 2008; 16 (1): 22–7.
2. Andersson G. Epidemiological features of chronic low back pain. Lancet 1999; 354: 581–6.
3. Van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth 2013; 1: 13–8.
4. Oren O, Ablin J. Precision medicine: the emerging approach to the chronic pain patient. Int J Clin Rheumtol 2013; 4: 491–9.
5. Боль: современные подходы в диагностике и лечении. Неврология и Ревматология (Прил. к журн. Consilium Medicum). 2016; 1; 55–7. / Pain: current approaches in diagnosis and treatment. Neurology and Rheumatology (Suppl. Consilium Medicum). 2016; 1; 55–7. [in Russian]
6. Хайне Х. Иммунологическая воспалительная реакция, вызванная антигомотоксической терапией воспалительных заболеваний суставов. Биологическая мед. 1999; 1: 5–8. / Khaine Kh. Immunologicheskaia vospalitel'naia reaktsiia, vyzvannaia antigomotoksicheskoi terapiei vospalitel'nykh zabolevanii sustavov. Biologicheskaia med. 1999; 1: 5–8. [in Russian]
7. Пилипович А.А. Хроническая боль при заболеваниях опорно-двигательного аппарата: применение антигомотоксических препаратов. Consilium Medicum. 2016; 18 (9): 128–32. / Pilipovich A.A. Chronic pain in diseases of the musculoskeletal system: the use of antihomotoxic medications. Consilium Medicum. 2016; 18 (9): 128–32. [in Russian]
8. Van Haselen R. An Integrative Review of the Evidence on the Antihomotoxic Medication Traumeel. 1–29.
9. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. CEBM Web site. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf. Accessed February 22, 2017.
10. Schneider C. Traumeel: an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med 2011; 4: 225–34.
11. Müller-Löbnitz C, Göthel D. Review of the clinical efficacy of the multicomponent combination medication Traumeel and its components. Altern Ther Health Med 2011; 17 (Suppl. 2): s18–s31.
12. Speed C, Wolfarth B. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Curr Med Res Opin 2014; 30 (5): 953–9.
13. Conforti A, Bertani S, Metelmann H et al. Experimental studies on the anti-inflammatory activity of a homeopathic preparation. Biomed Ther 1997; 15 (1): 28–31.
14. Conforti A, Bertani S, Lussignoli S, Bellavite P. Wirkungen Antihomotoxischer Präparate auf akute und chronische Entzündungen. Biol Medizin 1998; 27 (2): 63–6.
15. Enbergs H. The effect of selected potentiated suis organ preparations and Traumeel on phagocyte and lymphocyte activity. Biomed Ther 1998; 16 (2): 178–85.
16. Lussignoli S, Bertani S, Metelmann H et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med 1999; 7 (4): 225–30.
17. Heine H, Andrä F. On the anti-inflammatory mechanism of action of an antihomotoxic compound remedy [in German]. Ärztezeitschriftfür Naturheilverfahren 2002; 43 (2): 96–104.
18. Porozov S, Cahalon L, Weiser M et al. Inhibition of IL-1b and TNF-a secretion from resting and activated human immunocytes by the homeopathic medication Traumeel® S. Clin Dev Immunol 2004; 11 (2): 143–9.
19. Seilheimer B, Wierzchacz C, Gebhardt R. Influence of Traumeel on cultured chondrocytes and recombinant human matrix metalloproteinases: implications for chronic joint diseases. Eur J Integr Med 2009; 1 (4): 252–3.
20. St Laurent G, Tackett M, McCaffrey T, Kapranov P. Deep sequencing transcriptome analysis of Traumeel therapeutic action in wound healing (THU0016). Ann Rheum Dis 2013; 72 (Suppl. 3).
21. Zell J, Connert WD, Mau J, Feuerstake G. Behandlung von Sprunggelenksdistorsionen: Doppelblindstudie zum Wirksamkeitsnachweis eines homöopathischen Salbenpräparats. Fortschr Med 1988; 106 (5): 96–100.
22. Zell J, Connert WD, Mau J, Feuerstake G. Treatment of acute sprains of the ankle: a controlled double-blind trial to test the effectiveness of a homeopathic ointment. Biol Ther 1989; 7 (1): 1–6.
23. Thiel W, Borho B. Posttraumatische Kniegelenksergüsse und intraartikuläre Traumeel-N-Injektion. Orthopädische Prax 1991; 27 (11): 721–5.
24. Thiel W, Borho B. The treatment of recent traumatic blood effusions of the knee joint. Biol Ther 1994; 12 (4): 242–8.
25. Böhmer D, Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled double-blind study. Biol Ther 1992; 10 (4): 290–300.
26. Arora S, Harris T, Scherer C. Clinical safety of a homeopathic preparation. Biomed Ther 2000; 18 (2): 222–5.
27. González de Vega C, Speed C, Wolfarth B, González J. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: A multicentre, randomised, blinded, controlled and non-inferiority trial. Int J Clin Pract 2013; 67 (10): 979–89.
28. González de Vega C, Gonzáles J. A randomized, controlled, multicenter study on the effectiveness of Traumeel (ointment and gel) in terms of pain reduction and function improvement compared with diclofenac gel in acute ankle sprain. Ann Rheum Dis 2012; 71 (Suppl. 3): SAT0423.
29. Lozada C, del Rio E, Reitberg D et al. A multi-center double-blind, randomized, controlled trial (db-RCT) to evaluate the effectiveness and safety of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections versus IA placebo in patients with moderate-to-severe pain associated with OA of the knee. Arthritis Rheum 2014; 66 (Suppl.): S1266.
30. Lozada C, del Rio E, Reitberg DP et al. Risk-benefit of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections in patients with moderate-to-severe pain associated with OA of the knee (OAK) (THU0441). Ann Rheum Dis 2015; 74 (Suppl. 2): 4268.
31. Zenner S, Metelmann H. Application possibilities of Traumeel S injection solution: Results of a multicentric drug monitoring trial conducted on 3,241 patients. Biol Ther 1992; 10 (4): 301–10.
32. Zenner S, Metelmann H. Therapy experiences with a homeopathic ointment: Results of drug surveillance conducted on 3,422 patients. Biol Ther 1994; 12 (3): 204–11.
33. Weiser M, Zenner S. Orale Therapie traumatischer, entzündlicher und degenerativer Affektionen mit einem Homöopathikum. Biol Medizin 1996; 25 (5): 211–16.
34. Zenner S, Weiser M. Oral treatment of traumatic, inflammatory, and degenerative conditions with a homeopathic remedy. Biomed Ther 1997; 15 (1): 22–6.
35. Ludwig J, Weiser M. Treating pediatric trauma with a homeopathic ointment. J Biomed Ther 2001; 2: 8–11.
36. Birnesser H, Oberbaum M, Klein P, Weiser M. The homeopathic preparation Traumeel S compared with NSAIDs for symptomatic treatment of epicondylitis. J Musculoskelet Res 2004; 8 (2, 3): 119–28.
37. Schneider C, Klein P, Stolt P, Oberbaum M. A homeopathic ointment preparation compared with 1% diclofenac gel for acute symptomatic treatment of tendinopathy. Explore (NY). 2005; 1 (6): 446–52.
38. Schneider C, Schneider B, Hanisch J, van Haselen R. The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med 2008; 16 (1): 22–7.
________________________________________________
2. Andersson G. Epidemiological features of chronic low back pain. Lancet 1999; 354: 581–6.
3. Van Hecke O, Torrance N, Smith BH. Chronic pain epidemiology and its clinical relevance. Br J Anaesth 2013; 1: 13–8.
4. Oren O, Ablin J. Precision medicine: the emerging approach to the chronic pain patient. Int J Clin Rheumtol 2013; 4: 491–9.
5. Pain: current approaches in diagnosis and treatment. Neurology and Rheumatology (Suppl. Consilium Medicum). 2016; 1; 55–7. [in Russian]
6. Khaine Kh. Immunologicheskaia vospalitel'naia reaktsiia, vyzvannaia antigomotoksicheskoi terapiei vospalitel'nykh zabolevanii sustavov. Biologicheskaia med. 1999; 1: 5–8. [in Russian]
7. Pilipovich A.A. Chronic pain in diseases of the musculoskeletal system: the use of antihomotoxic medications. Consilium Medicum. 2016; 18 (9): 128–32. [in Russian]
8. Van Haselen R. An Integrative Review of the Evidence on the Antihomotoxic Medication Traumeel. 1–29.
9. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. CEBM Web site. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf. Accessed February 22, 2017.
10. Schneider C. Traumeel: an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med 2011; 4: 225–34.
11. Müller-Löbnitz C, Göthel D. Review of the clinical efficacy of the multicomponent combination medication Traumeel and its components. Altern Ther Health Med 2011; 17 (Suppl. 2): s18–s31.
12. Speed C, Wolfarth B. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Curr Med Res Opin 2014; 30 (5): 953–9.
13. Conforti A, Bertani S, Metelmann H et al. Experimental studies on the anti-inflammatory activity of a homeopathic preparation. Biomed Ther 1997; 15 (1): 28–31.
14. Conforti A, Bertani S, Lussignoli S, Bellavite P. Wirkungen Antihomotoxischer Präparate auf akute und chronische Entzündungen. Biol Medizin 1998; 27 (2): 63–6.
15. Enbergs H. The effect of selected potentiated suis organ preparations and Traumeel on phagocyte and lymphocyte activity. Biomed Ther 1998; 16 (2): 178–85.
16. Lussignoli S, Bertani S, Metelmann H et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med 1999; 7 (4): 225–30.
17. Heine H, Andrä F. On the anti-inflammatory mechanism of action of an antihomotoxic compound remedy [in German]. Ärztezeitschriftfür Naturheilverfahren 2002; 43 (2): 96–104.
18. Porozov S, Cahalon L, Weiser M et al. Inhibition of IL-1b and TNF-a secretion from resting and activated human immunocytes by the homeopathic medication Traumeel® S. Clin Dev Immunol 2004; 11 (2): 143–9.
19. Seilheimer B, Wierzchacz C, Gebhardt R. Influence of Traumeel on cultured chondrocytes and recombinant human matrix metalloproteinases: implications for chronic joint diseases. Eur J Integr Med 2009; 1 (4): 252–3.
20. St Laurent G, Tackett M, McCaffrey T, Kapranov P. Deep sequencing transcriptome analysis of Traumeel therapeutic action in wound healing (THU0016). Ann Rheum Dis 2013; 72 (Suppl. 3).
21. Zell J, Connert WD, Mau J, Feuerstake G. Behandlung von Sprunggelenksdistorsionen: Doppelblindstudie zum Wirksamkeitsnachweis eines homöopathischen Salbenpräparats. Fortschr Med 1988; 106 (5): 96–100.
22. Zell J, Connert WD, Mau J, Feuerstake G. Treatment of acute sprains of the ankle: a controlled double-blind trial to test the effectiveness of a homeopathic ointment. Biol Ther 1989; 7 (1): 1–6.
23. Thiel W, Borho B. Posttraumatische Kniegelenksergüsse und intraartikuläre Traumeel-N-Injektion. Orthopädische Prax 1991; 27 (11): 721–5.
24. Thiel W, Borho B. The treatment of recent traumatic blood effusions of the knee joint. Biol Ther 1994; 12 (4): 242–8.
25. Böhmer D, Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled double-blind study. Biol Ther 1992; 10 (4): 290–300.
26. Arora S, Harris T, Scherer C. Clinical safety of a homeopathic preparation. Biomed Ther 2000; 18 (2): 222–5.
27. González de Vega C, Speed C, Wolfarth B, González J. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: A multicentre, randomised, blinded, controlled and non-inferiority trial. Int J Clin Pract 2013; 67 (10): 979–89.
28. González de Vega C, Gonzáles J. A randomized, controlled, multicenter study on the effectiveness of Traumeel (ointment and gel) in terms of pain reduction and function improvement compared with diclofenac gel in acute ankle sprain. Ann Rheum Dis 2012; 71 (Suppl. 3): SAT0423.
29. Lozada C, del Rio E, Reitberg D et al. A multi-center double-blind, randomized, controlled trial (db-RCT) to evaluate the effectiveness and safety of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections versus IA placebo in patients with moderate-to-severe pain associated with OA of the knee. Arthritis Rheum 2014; 66 (Suppl.): S1266.
30. Lozada C, del Rio E, Reitberg DP et al. Risk-benefit of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections in patients with moderate-to-severe pain associated with OA of the knee (OAK) (THU0441). Ann Rheum Dis 2015; 74 (Suppl. 2): 4268.
31. Zenner S, Metelmann H. Application possibilities of Traumeel S injection solution: Results of a multicentric drug monitoring trial conducted on 3,241 patients. Biol Ther 1992; 10 (4): 301–10.
32. Zenner S, Metelmann H. Therapy experiences with a homeopathic ointment: Results of drug surveillance conducted on 3,422 patients. Biol Ther 1994; 12 (3): 204–11.
33. Weiser M, Zenner S. Orale Therapie traumatischer, entzündlicher und degenerativer Affektionen mit einem Homöopathikum. Biol Medizin 1996; 25 (5): 211–16.
34. Zenner S, Weiser M. Oral treatment of traumatic, inflammatory, and degenerative conditions with a homeopathic remedy. Biomed Ther 1997; 15 (1): 22–6.
35. Ludwig J, Weiser M. Treating pediatric trauma with a homeopathic ointment. J Biomed Ther 2001; 2: 8–11.
36. Birnesser H, Oberbaum M, Klein P, Weiser M. The homeopathic preparation Traumeel S compared with NSAIDs for symptomatic treatment of epicondylitis. J Musculoskelet Res 2004; 8 (2, 3): 119–28.
37. Schneider C, Klein P, Stolt P, Oberbaum M. A homeopathic ointment preparation compared with 1% diclofenac gel for acute symptomatic treatment of tendinopathy. Explore (NY). 2005; 1 (6): 446–52.
38. Schneider C, Schneider B, Hanisch J, van Haselen R. The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med 2008; 16 (1): 22–7.
Авторы
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.